These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 6152684

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Human subjects research. Pediatric study of ADHD drug draws high-level public review.
    Couzin J.
    Science; 2004 Aug 20; 305(5687):1088-9. PubMed ID: 15326317
    [No Abstract] [Full Text] [Related]

  • 24. Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling.
    Rowe DL, Robinson PA, Gordon E.
    Clin Neurophysiol; 2005 Feb 20; 116(2):324-35. PubMed ID: 15661111
    [Abstract] [Full Text] [Related]

  • 25. Response to Brasić (2007): psychomotor study of children with ADHD.
    Pedersen SJ.
    Percept Mot Skills; 2008 Jun 20; 106(3):891-2. PubMed ID: 18712212
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M.
    Mol Psychiatry; 2004 Jul 20; 9(7):718-26. PubMed ID: 14699433
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX, Acosta MT.
    Rev Neurol; 2011 Mar 01; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA, Faraone SV.
    Expert Rev Neurother; 2007 Apr 01; 7(4):351-62. PubMed ID: 17425490
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC, Cox DJ.
    J Psychopharmacol; 2008 May 01; 22(3):227-9. PubMed ID: 18541623
    [No Abstract] [Full Text] [Related]

  • 36. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep 01; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 37. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
    Caballero M, Núñez F, Ahern S, Cuffí ML, Carbonell L, Sánchez S, Fernández-Dueñas V, Ciruela F.
    Neurosci Lett; 2011 Apr 20; 494(1):44-8. PubMed ID: 21362462
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.